Event 2012 - Speakers & Topics
Session 1: Theory Meets Reality: Has the Era of Personalized Medicine Come to Norway? Are We Prepared?
James Peach, Director Stratified Medicine at Cancer Research UK, London
- Stratified Medicines Programme: Tumour Profiling and Data Capture to Improve Cancer Care
- Programme for Optimized Treatment of Norwegian Cancer Patients ‐ Status, Challenges and
- New Drug Discovery in the Era of Personalized Medicine / Selection of Tumour Types and
Core Session: How Does Personalized Medicine Affect Drug Development and
Treatment? Perspectives from Norwegian Tumour Groups
Treatment? Perspectives from Norwegian Tumour Groups
- Lymphoma Group – Research and Clinical Perspective
- Melanoma Group – Research and Clinical Perspective
- CML Group: Collaboration on a Nordic and European level
- Breast Cancer and Gynaecological Cancer Group: Heterogeneity of Breast Cancer; a Challenge for Successful Treatment
Closing Session: New Drugs for Norwegian Patients – Current Climate for the Approval of Innovative Drugs
Steinar Aamdal, Oslo University Hospital
Torunn Wangen, Head of the oncology assessors team, Norwegian Medicines Agency
Speaker from Helsedirektorate (invited)
Nils Wilking, Karolinska University Hospital Stockholm
Steinar Aamdal, Oslo University Hospital
- Introduction – A Clinicians Perspective
Torunn Wangen, Head of the oncology assessors team, Norwegian Medicines Agency
- How does SLV Evaluate New Cancer Drugs?
Speaker from Helsedirektorate (invited)
- Reimbursement of Innovative Treatments in Norway – Status, Challenges and Outlook
Nils Wilking, Karolinska University Hospital Stockholm
- International Perspectives: Funding Innovative Treatments and Market Uptake
A complete program for Cancer Crosslinks 2012 may be downloaded HERE.
Event 2012 - Sponsors
|
|